Next-generation vaccine platforms for COVID-19
Source abstract
Abstract
Consensus among experts is that only an effective COVID-19 vaccine will end the pandemic. This Comment focuses on how this pandemic has accelerated the development of vaccine platforms distinct from classical vaccines; these novel platforms may also increase the response time when new viruses emerge in the future.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Viral Infections and Outbreaks Research · SARS-CoV-2 and COVID-19 Research · COVID-19 epidemiological studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (21)
Show source-provided references
1. Chan, P. K. S. Clin. Infect. Dis. 34, S58–S64 (2002).10.1086/338820 ↗
2. Iskander, J., Strikas, R. A., Gensheimer, K. F., Cox, N. J. & Redd, S. C. Emerg. Infect. Dis. 19, 879–885 (2013).10.3201/eid1906.121478 ↗
3. Cumulative Number of Confirmed Human Cases for Avian Influenza A(H5N1) Reported to WHO, 2003–2020 (WHO, 2020); https://www.who.int/influenza/human_animal_interface/2020_MAY_tableH5N1.pdf?ua=1
4. Summary of Probable SARS Cases with Onset of Illness from 1 November 2002 to 31 July 2003 (WHO, 2003); https://www.who.int/csr/sars/country/table2004_04_21/en/
5. Wong, J. Y. et al. Epidemiology 24, 830–841 (2013).10.1097/EDE.0b013e3182a67448 ↗
6. Bausch, D. G. Curr. Top. Microbiol. Immunol. 411, 63–92 (2017).
7. Mehand, M. S., Al-Shorbaji, F., Millett, P. & Murgue, B. Antiviral Res. 159, 63–67 (2018).10.1016/j.antiviral.2018.09.009 ↗
8. DRAFT Landscape of COVID-19 Candidate Vaccines (WHO, 2020); https://www.who.int/who-documents-detail/draft-landscape-of-covid-19-candidate-vaccines
9. Greenwood, B. Philos. Trans. R. Soc. Lond. B 369, 20130433 (2014).10.1098/rstb.2013.0433 ↗
10. Patel, C. et al. Euro. Surveill. 23, 30–40 (2018).10.2807/1560-7917.ES.2018.23.41.1700737 ↗
11. Henao-Restrepo, A. M. et al. Lancet 389, 505–518 (2017).10.1016/S0140-6736(16)32621-6 ↗
12. Vogel, A. B. et al. Mol. Ther. 26, 446–455 (2018).10.1016/j.ymthe.2017.11.017 ↗
13. Graham, B. S. Science 368, 945–946 (2020).10.1126/science.abb8923 ↗
14. Randolph, H. E. & Barreiro, L. B. Immunity 52, 737–741 (2020).10.1016/j.immuni.2020.04.012 ↗
15. Ten Threats to Global Health in 2019 (WHO, 2019); https://www.who.int/news-room/feature-stories/ten-threats-to-global-health-in-2019
16. Coconel Group Lancet Infect. Dis. 20, 769–770 (2020).
17. Ciabattini, A. et al. Semin. Immunol. 40, 83–94 (2018).10.1016/j.smim.2018.10.010 ↗
18. Sheridan, P. A. et al. Int. J. Obes. 36, 1072–1077 (2012).10.1038/ijo.2011.208 ↗
19. Thanh Le, T. et al. Nat. Rev. Drug Discov. 19, 305–306 (2020).10.1038/d41573-020-00073-5 ↗
20. McLean, K. A., Goldin, S., Nannei, C., Sparrow, E. & Torelli, G. Vaccine 34, 5410–5413 (2016).10.1016/j.vaccine.2016.08.019 ↗
21. Craven, J. COVID-19 Vaccine Tracker (RAPS, 2020); https://www.raps.org/news-and-articles/news-articles/2020/3/covid-19-vaccine-tracker